home
portfolio
approach
team
careers
news
contact
investor portal
home
portfolio
approach
team
careers
news
contact
investor portal
Nextech Invest
Kinnate Biopharma Inc. Announces FDA Clearance of Investigational Drug Application for KIN-3248
Kinnate Biopharma Inc. Announces FDA Clearance of Investigational Drug Application for KIN-3248
Post navigation
Previous Post
Previous
Amgen and Arrakis Therapeutics Announce Multi-Target Collaboration to Identify Novel RNA Degrader Small Molecule Therapeutics
Next Post
Next
Scorpion Therapeutics Enters Agreement with Astrazeneca to Discover, Develop and Commercialize Novel Cancer Treatments Against Undruggable Targets